XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Reporting
9 Months Ended
Sep. 30, 2024
Segment Reporting  
Segment Reporting

14.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses. Among other measures, we assess and measure segment operating results based on net income from continuing operations attributable to Icahn Enterprises. Certain terms of financings for certain of our businesses impose restrictions on the business’ ability to transfer funds to us, including restrictions on dividends, distributions, loans and other transactions.

Condensed Statements of Operations

Three Months Ended September 30, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,834

$

206

$

101

$

6

$

47

$

27

$

$

2,221

Other revenues from operations

 

 

 

168

 

 

23

 

 

1

 

 

192

Net gain from investment activities

 

257

 

 

 

 

 

 

 

 

257

Interest and dividend income

 

77

 

10

 

1

 

 

1

 

 

 

26

 

115

Loss on disposition of assets, net

 

 

 

(1)

 

 

 

 

 

 

(1)

Other income (loss), net

 

 

2

 

 

(1)

 

 

(3)

 

1

 

8

 

7

 

334

 

1,846

 

374

 

100

 

30

 

44

 

29

 

34

 

2,791

Expenses:

Cost of goods sold

 

 

1,914

 

167

 

86

 

5

 

38

 

13

 

 

2,223

Other expenses from operations

 

 

 

137

 

 

18

 

 

 

 

155

Dividend expense

 

14

 

 

 

 

 

 

 

 

14

Selling, general and administrative

 

5

 

47

 

102

 

12

 

5

 

10

 

12

 

9

 

202

Restructuring, net

Credit loss on related party note receivable

 

 

 

 

 

 

 

 

 

Loss on deconsolidation of subsidiary

Interest expense

 

19

 

27

 

1

 

2

 

 

1

 

 

80

 

130

 

38

 

1,988

 

407

 

100

 

28

 

49

 

25

 

89

 

2,724

Income (loss) before income tax benefit (expense)

 

296

 

(142)

 

(33)

 

 

2

 

(5)

 

4

 

(55)

 

67

Income tax benefit (expense)

 

 

8

 

9

 

 

 

 

 

(4)

 

13

Net income (loss)

 

296

 

(134)

 

(24)

 

 

2

 

(5)

 

4

 

(59)

 

80

Less: net income (loss) attributable to non-controlling interests

 

104

 

(46)

 

 

 

 

 

 

 

58

Net income (loss) attributable to Icahn Enterprises

$

192

$

(88)

$

(24)

$

$

2

$

(5)

$

4

$

(59)

$

22

Supplemental information:

Capital expenditures

$

$

34

$

12

$

5

$

6

$

1

$

$

$

58

Depreciation and amortization

$

$

90

$

19

$

5

$

3

$

2

$

7

$

$

126

Three Months Ended September 30, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

2,522

$

264

$

105

$

29

$

46

$

25

$

$

2,991

Other revenues from operations

 

 

 

180

 

 

22

 

 

1

 

 

203

Net loss from investment activities

 

(332)

 

 

 

 

 

 

 

 

(332)

Interest and dividend income

 

108

 

10

 

1

 

 

 

 

 

24

 

143

(Loss) gain on disposition of assets, net

 

 

(1)

 

3

 

 

 

 

 

 

2

Other income (loss), net

 

 

4

 

 

(2)

 

 

1

 

 

 

3

 

(224)

 

2,535

 

448

 

103

 

51

 

47

 

26

 

24

 

3,010

Expenses:

Cost of goods sold

 

 

2,048

 

174

 

83

 

20

 

37

 

15

 

 

2,377

Other expenses from operations

 

 

 

148

 

 

17

 

 

 

 

165

Dividend expense

 

21

 

 

 

 

 

 

 

 

21

Selling, general and administrative

 

3

 

43

 

116

 

14

 

4

 

9

 

11

 

9

 

209

Restructuring, net

 

1

 

1

Credit loss on related party note receivable

 

 

 

 

 

 

 

23

23

Loss on deconsolidation of subsidiary

Interest expense

49

 

22

 

2

 

3

 

 

1

 

 

71

148

 

73

 

2,113

 

440

 

100

 

41

 

48

 

26

 

103

 

2,944

(Loss) income before income tax (expense) benefit

 

(297)

 

422

 

8

 

3

 

10

 

(1)

 

 

(79)

 

66

Income tax (expense) benefit

 

 

(80)

 

(1)

 

(3)

 

 

 

 

(12)

 

(96)

Net (loss) income

 

(297)

 

342

 

7

 

 

10

 

(1)

 

 

(91)

 

(30)

Less: net (loss) income attributable to non-controlling interests

 

(131)

 

107

 

 

 

 

 

 

 

(24)

Net (loss) income attributable to Icahn Enterprises

$

(166)

$

235

$

7

$

$

10

$

(1)

$

$

(91)

$

(6)

Supplemental information:

Capital expenditures

$

$

50

$

17

$

2

$

$

1

$

$

$

70

Depreciation and amortization

$

$

96

$

17

$

6

$

4

$

2

$

7

$

1

$

133

Nine Months Ended September 30, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

5,663

$

637

$

307

$

17

$

127

$

76

$

$

6,827

Other revenues from operations

 

 

 

504

 

 

59

 

 

3

 

 

566

Net loss from investment activities

 

(318)

 

 

 

 

 

 

 

 

(318)

Interest and dividend income

 

269

 

30

 

3

 

 

1

 

 

1

 

76

 

380

Loss on disposition of assets, net

 

 

(1)

 

(5)

 

 

 

 

 

 

(6)

Other income (loss), net

 

 

10

 

 

(3)

 

 

(3)

 

1

 

8

 

13

 

(49)

 

5,702

 

1,139

 

304

 

77

 

124

 

81

 

84

 

7,462

Expenses:

Cost of goods sold

 

 

5,549

 

461

 

252

 

13

 

98

 

41

 

 

6,414

Other expenses from operations

 

 

 

412

 

 

50

 

 

 

 

462

Dividend expense

47

 

 

 

 

 

 

 

 

47

Selling, general and administrative

 

15

 

124

 

303

 

36

 

14

 

31

 

32

 

23

 

578

Restructuring, net

1

1

Interest expense

 

63

 

86

 

2

 

8

 

 

1

 

 

234

 

394

 

125

 

5,759

 

1,178

 

297

 

77

 

130

 

73

 

257

 

7,896

(Loss) income before income tax (expense) benefit

 

(174)

 

(57)

 

(39)

 

7

 

 

(6)

 

8

 

(173)

 

(434)

Income tax benefit (expense)

 

 

26

 

13

 

(3)

 

 

 

 

(34)

 

2

Net (loss) income

 

(174)

 

(31)

 

(26)

 

4

 

 

(6)

 

8

 

(207)

 

(432)

Less: net (loss) income attributable to non-controlling interests

 

(86)

 

 

 

1

 

 

 

 

 

(85)

Net (loss) income attributable to Icahn Enterprises

$

(88)

$

(31)

$

(26)

$

3

$

$

(6)

$

8

$

(207)

$

(347)

Supplemental information:

Capital expenditures

$

$

124

$

40

$

10

$

15

$

3

$

$

$

192

Depreciation and amortization

$

$

272

$

56

$

18

$

10

$

5

$

21

$

$

382

Nine Months Ended September 30, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

7,045

$

799

$

340

$

49

$

132

$

68

$

$

8,433

Other revenues from operations

 

 

 

527

 

 

58

 

 

3

 

 

588

Net loss from investment activities

 

(1,275)

 

 

 

 

 

 

 

 

(1,275)

Interest and dividend income

 

386

 

23

 

1

 

 

 

 

 

71

 

481

(Loss) gain on disposition of assets, net

 

(1)

 

6

 

 

 

 

 

 

5

Other income (loss), net

 

1

 

10

 

 

(8)

 

1

 

1

 

1

 

 

6

 

(888)

 

7,077

 

1,333

 

332

 

108

 

133

 

72

 

71

 

8,238

Expenses:

 

Cost of goods sold

 

 

5,964

 

540

 

264

 

34

 

104

 

41

 

 

6,947

Other expenses from operations

 

 

 

435

 

 

48

 

 

 

 

483

Dividend expense

 

68

 

 

 

 

 

 

 

 

68

Selling, general and administrative

 

19

 

128

 

362

 

43

 

13

 

29

 

35

 

24

 

653

Restructuring, net

 

 

 

 

 

 

1

 

 

 

1

Credit loss on related party note receivable

139

139

Loss on deconsolidation of subsidiary

 

246

246

Interest expense

 

132

 

67

 

3

 

9

 

 

1

 

 

214

 

426

 

219

 

6,159

 

1,340

 

316

 

95

 

135

 

76

 

623

 

8,963

(Loss) income before income tax (expense) benefit

 

(1,107)

 

918

 

(7)

 

16

 

13

 

(2)

 

(4)

 

(552)

 

(725)

Income tax (expense) benefit

 

 

(173)

 

5

 

(4)

 

 

 

 

90

 

(82)

Net (loss) income

 

(1,107)

 

745

 

(2)

 

12

 

13

 

(2)

 

(4)

 

(462)

 

(807)

Less: net (loss) income attributable to non-controlling interests

 

(555)

 

292

 

 

1

 

 

 

 

 

(262)

Net (loss) income attributable to Icahn Enterprises

$

(552)

$

453

$

(2)

$

11

$

13

$

(2)

$

(4)

$

(462)

$

(545)

Supplemental information:

 

Capital expenditures

$

$

150

$

38

$

9

$

2

$

2

$

$

$

201

Depreciation and amortization

$

$

269

$

58

$

20

$

10

$

5

$

21

$

1

$

384

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2024

    

2023

    

2024

    

2023

(in millions)

Petroleum products

$

1,709

$

2,392

5,277

$

6,505

Nitrogen fertilizer products

 

125

 

130

 

386

 

540

$

1,834

$

2,522

$

5,663

$

7,045

Automotive

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2024

    

2023

    

2024

    

2023

(in millions)

Automotive Services

$

355

$

406

$

1,074

$

1,167

Aftermarket Parts

 

4

 

24

 

22

 

116

Total revenue from customers

$

359

$

430

1,096

1,283

Lease revenue outside the scope of ASC 606

15

14

45

43

Total Automotive net sales and other revenues from operations

$

374

$

444

$

1,141

$

1,326

Condensed Balance Sheets

September 30, 2024

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

5

$

534

$

111

$

6

$

27

$

5

$

40

$

1,566

$

2,294

Cash held at consolidated affiliated partnerships and restricted cash

 

2,254

 

 

6

 

 

2

 

3

 

 

175

 

2,440

Investments

 

2,476

 

95

 

 

 

14

 

 

 

 

2,585

Accounts receivable, net

 

 

281

 

34

 

83

 

18

 

28

 

32

 

 

476

Inventories, net

 

 

498

 

156

 

111

 

 

96

 

22

 

 

883

Related party notes receivable, net

7

7

Property, plant and equipment, net

 

 

2,503

 

810

 

126

 

370

 

52

 

 

4

 

3,865

Goodwill and intangible assets, net

 

 

164

 

329

 

22

 

 

20

 

177

 

 

712

Other assets

 

3,013

 

307

 

484

 

99

 

65

 

17

 

7

 

189

 

4,181

Total assets

$

7,748

$

4,382

$

1,930

$

447

$

496

$

221

$

278

$

1,941

$

17,443

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

802

$

1,497

$

811

$

117

$

47

$

43

$

57

$

116

$

3,490

Securities sold, not yet purchased, at fair value

 

2,679

 

 

 

 

 

 

 

 

2,679

Debt

 

 

1,582

 

24

 

142

 

2

 

14

 

 

4,683

 

6,447

Total liabilities

 

3,481

 

3,079

 

835

 

259

 

49

 

57

 

57

 

4,799

 

12,616

Equity attributable to Icahn Enterprises

 

2,745

 

664

 

1,095

 

172

 

442

 

164

 

221

 

(2,858)

 

2,645

Equity attributable to non-controlling interests

 

1,522

 

639

 

 

16

 

5

 

 

 

 

2,182

Total equity

 

4,267

 

1,303

 

1,095

 

188

 

447

 

164

 

221

 

(2,858)

 

4,827

Total liabilities and equity

$

7,748

$

4,382

$

1,930

$

447

$

496

$

221

$

278

$

1,941

$

17,443

December 31, 2023

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

23

$

1,179

$

104

$

8

$

22

$

5

$

26

$

1,584

$

2,951

Cash held at consolidated affiliated partnerships and restricted cash

 

2,799

 

7

 

9

 

 

4

 

3

 

 

173

 

2,995

Investments

 

2,898

 

100

 

 

 

14

 

 

 

 

3,012

Accounts receivable, net

 

 

286

 

41

 

89

 

16

 

26

 

27

 

 

485

Related party note receivable, net

11

11

Inventories, net

 

 

604

 

228

 

111

 

 

81

 

23

 

 

1,047

Property, plant and equipment, net

 

 

2,594

 

822

 

134

 

363

 

52

 

 

4

 

3,969

Goodwill and intangible assets, net

 

 

179

 

335

 

23

 

 

19

 

198

 

 

754

Other assets

 

4,425

 

310

 

480

 

101

 

69

 

17

 

8

 

224

 

5,634

Total assets

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,312

$

1,553

$

890

$

148

$

43

$

42

$

55

$

62

$

4,105

Securities sold, not yet purchased, at fair value

 

3,473

 

 

 

 

 

 

 

 

3,473

Debt

 

 

2,185

 

33

 

133

 

1

 

8

 

 

4,847

 

7,207

Total liabilities

 

4,785

 

3,738

 

923

 

281

 

44

 

50

 

55

 

4,909

 

14,785

Equity attributable to Icahn Enterprises

 

3,243

 

795

 

1,096

 

168

 

439

 

153

 

227

 

(2,913)

 

3,208

Equity attributable to non-controlling interests

 

2,117

 

726

 

 

17

 

5

 

 

 

 

2,865

Total equity

 

5,360

 

1,521

 

1,096

 

185

 

444

 

153

 

227

 

(2,913)

 

6,073

Total liabilities and equity

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858